Actualités Cronos Group Inc - CRON | Actions Toronto Stock Exchange

Cronos Group Provides Bi-Weekly MCTO Status Update

TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or...

Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter

TORONTO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or...

Cronos Group Files Form 12b-25

TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or...

Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire

Arye Weigensberg Named Interim Head of Research and Development Search to Identify Permanent Successor Well...

Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy

Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using...

Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

TORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos...

Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference

TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or...

Cronos Group Appoints Bob Madore as Chief Financial Officer

TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or...

Cronos Group Reports 2021 Second Quarter Results

Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced...

Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies

SOURZ by Spinach™ gummies offer adult consumers a bold and juicy new cannabis edible featuring great tasting...

Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021

TORONTO, July 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or...

Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders

TORONTO, June 25, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or...

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company

Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market...

Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Be...

BOSTON and TORONTO, June 04, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos...

Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021

TORONTO, May 10, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cronos Group Inc (CRON)

Outils de qualité professionnelle, pour des investisseurs individuels.

CRON Actualités

Cronos Group Provides Bi-Weekly MCTO Status Update

Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter

Cronos Group Files Form 12b-25

Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire

Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy

Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference

Cronos Group Appoints Bob Madore as Chief Financial Officer

Cronos Group Reports 2021 Second Quarter Results

Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies

Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021

Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company

Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Be...

Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cronos Group Inc (CRON) Actualités

Cronos Group Inc (CRON)

Outils de qualité professionnelle, pour des investisseurs individuels.

CRON Actualités

Cronos Group Provides Bi-Weekly MCTO Status Update

Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter

Cronos Group Files Form 12b-25

Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire

Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy

Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference

Cronos Group Appoints Bob Madore as Chief Financial Officer

Cronos Group Reports 2021 Second Quarter Results

Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies

Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021

Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company

Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Be...

Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités